OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metformin promotes apoptosis in primary breast cancer cells by downregulation of cyclin D1 and upregulation of P53 through an AMPK-alpha independent mechanism
Güven Yenmiş, Nail Beşli, Elif Yaprak Saraç, et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020) Vol. 51, Iss. 2, pp. 826-834
Open Access | Times Cited: 18
Güven Yenmiş, Nail Beşli, Elif Yaprak Saraç, et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020) Vol. 51, Iss. 2, pp. 826-834
Open Access | Times Cited: 18
Showing 18 citing articles:
Anti-cancer effect of metformin on the metastasis and invasion of primary breast cancer cells through mediating NF-kB activity
Güven Yenmiş, Elif Yaprak Saraç, Nail Beşli, et al.
Acta Histochemica (2021) Vol. 123, Iss. 4, pp. 151709-151709
Closed Access | Times Cited: 34
Güven Yenmiş, Elif Yaprak Saraç, Nail Beşli, et al.
Acta Histochemica (2021) Vol. 123, Iss. 4, pp. 151709-151709
Closed Access | Times Cited: 34
Metformin: A promising drug for human cancers (Review)
Hongnian Wu, Dan Huang, Hong Zhou, et al.
Oncology Letters (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Hongnian Wu, Dan Huang, Hong Zhou, et al.
Oncology Letters (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 26
Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications
Sara S. Bashraheel, Hadeel Kheraldine, Sarah Khalaf, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114676-114676
Open Access | Times Cited: 12
Sara S. Bashraheel, Hadeel Kheraldine, Sarah Khalaf, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114676-114676
Open Access | Times Cited: 12
Codelivery of metformin and methotrexate with optimized chitosan nanoparticles for synergistic triple-negative breast cancer therapy in vivo
Alireza Karimian-Shaddel, Hamed Dadashi, Milad Mashinchian, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124897-124897
Closed Access | Times Cited: 2
Alireza Karimian-Shaddel, Hamed Dadashi, Milad Mashinchian, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124897-124897
Closed Access | Times Cited: 2
Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance
Bao Lam, Rashmi Srivastava, Jason Morvant, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3077-3077
Open Access | Times Cited: 16
Bao Lam, Rashmi Srivastava, Jason Morvant, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3077-3077
Open Access | Times Cited: 16
Metformin and Malignant Tumors: Not Over the Hill
Weiling Leng, Juan Jiang, Bing Chen, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 3673-3689
Open Access | Times Cited: 15
Weiling Leng, Juan Jiang, Bing Chen, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 3673-3689
Open Access | Times Cited: 15
Enhancing the anticancer potential of metformin: fabrication of efficient nanospanlastics, in vitro cytotoxic studies on HEP-2 cells and reactome enhanced pathway analysis
Shereen N. Raafat, Sara Abd El Wahed, Noha M. Badawi, et al.
International Journal of Pharmaceutics X (2023) Vol. 6, pp. 100215-100215
Open Access | Times Cited: 5
Shereen N. Raafat, Sara Abd El Wahed, Noha M. Badawi, et al.
International Journal of Pharmaceutics X (2023) Vol. 6, pp. 100215-100215
Open Access | Times Cited: 5
Non-coding RNAs as potential targets in metformin therapy for cancer
Yihan Zhang, Yunhao Wu, Zixu Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Yihan Zhang, Yunhao Wu, Zixu Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma
Xiaolong Qiao, Yinan Chen, Zixuan Wang, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 12, pp. 1702-1714
Closed Access | Times Cited: 4
Xiaolong Qiao, Yinan Chen, Zixuan Wang, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 12, pp. 1702-1714
Closed Access | Times Cited: 4
Metformin Induces PRODH/POX-Dependent Apoptosis in Breast Cancer Cells
Thi Yen Ly Huynh, Ilona Ościłowska, Łukasz Szoka, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6
Thi Yen Ly Huynh, Ilona Ościłowska, Łukasz Szoka, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 6
Examining the Effect of Metformin on Cell Death Mechanisms in Relation to Hippo Signaling in MDA-MB-231 Breast Cancer Cells
Özge Rencüzoğulları, Zeynep Gülşah Sonalp
Cumhuriyet Science Journal (2024) Vol. 45, Iss. 2, pp. 227-234
Open Access
Özge Rencüzoğulları, Zeynep Gülşah Sonalp
Cumhuriyet Science Journal (2024) Vol. 45, Iss. 2, pp. 227-234
Open Access
Metformin induces ferroptosis and suppresses malignant behaviors in diabetic breast cancer
Tao Chen, Xiaoxin Li, Yuan Li, et al.
Research Square (Research Square) (2024)
Closed Access
Tao Chen, Xiaoxin Li, Yuan Li, et al.
Research Square (Research Square) (2024)
Closed Access
Metformin boosts doxorubicin efficacy and increases CD8 + T cell frequency in mouse breast cancer
Elaheh Hassani, Sahand Mozzendizaji, Vahid Shafiei‐Irannejad, et al.
Clinical & Translational Oncology (2024)
Closed Access
Elaheh Hassani, Sahand Mozzendizaji, Vahid Shafiei‐Irannejad, et al.
Clinical & Translational Oncology (2024)
Closed Access
Antiproliferative Mechanisms of Metformin in Breast Cancer: A Systematic Review of the Literature
Aiman Moldasheva, Assem Zhakupova, Mohamad Aljofan
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 247-247
Open Access
Aiman Moldasheva, Assem Zhakupova, Mohamad Aljofan
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 247-247
Open Access
Keratin19 promotes pancreatic cancer progression and poor prognosis via activating the Hedgehog pathway
Changsheng Zhou, Yi Xiang, Yantao Ren, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 3
Open Access | Times Cited: 1
Changsheng Zhou, Yi Xiang, Yantao Ren, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 3
Open Access | Times Cited: 1
ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells
Shizhe Li, Jiancheng Xue, He Zhang, et al.
Journal of Orthopaedic Surgery and Research (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Shizhe Li, Jiancheng Xue, He Zhang, et al.
Journal of Orthopaedic Surgery and Research (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers
Md. Imtiazul Kabir, Robin Kumar, Lakshmi Sai Pratyusha Bugata, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 284-328
Closed Access
Md. Imtiazul Kabir, Robin Kumar, Lakshmi Sai Pratyusha Bugata, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 284-328
Closed Access
In vitro ve in silico analizi ile metforminin meme tümörü hücrelerinde protein profili üzerindeki etkinliği
Güven Yenmiş, Nail Beşli
Ege Tıp Dergisi (2022) Vol. 61, Iss. 2, pp. 215-224
Open Access
Güven Yenmiş, Nail Beşli
Ege Tıp Dergisi (2022) Vol. 61, Iss. 2, pp. 215-224
Open Access
